Open AccessAntiplatelet Medications in Hemodialysis Patients
Author(s) -
Swapnil Hiremath,
Rachel M. Holden,
Dean Fergusson,
Deborah Zimmerman
Publication year - 2009
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.00810209
Subject(s) - medicine , hemodialysis , population , thrombosis , intensive care medicine , end stage renal disease , dialysis , meta analysis , surgery , environmental health
Patients with end stage renal disease (ESRD) are often prescribed antiplatelet medications. However, these patients are also at increased risk of bleeding compared with the general population, and an aim was made to quantify this risk with antiplatelet agents.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom